After-Hours Stock Movers 05/18: (LPTH) (PRPL) (TTWO) Higher; (IOVA) (QUIK) (LAD) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Lithia Motors (LAD) Prices 3.1M Share Common Offering at $322/Sh
May 20, 2021 5:50 AM EDTLithia Motors & Driveway (NYSE: LAD) today announced the pricing of its public offering (the "Offering") of 3,105,590 shares of its Class A common stock (the "common stock") at a price to the public of $322.00 per share. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 465,838 shares of common stock at the same public offering price, less underwriting discounts and commissions. The offering is expected to close on May 24, 2021, subject to the satisfaction of customary closing conditions.
In addition, today Lithia concurrently announced the pricing of its private... More
Iovanace Biotherapeutics (IOVA) Has Strong Cash Cushion Even as CEO Exit Adds to Uncertainties - Mizuho
May 19, 2021 12:42 PM EDTMizuho Securities analyst Mara Goldstein weighed in on Iovanace Biotherapeutics (NASDAQ: IOVA) after the company announced that Maria Fardis, Ph.D. will resign as President and CEO of the company following today's regulatory setback.
"The commercial potential for lifileucel remains but the question... More
Iovanace Biotherapeutics (IOVA) PT Lowered to $33 at Stifel on BLA Push
May 19, 2021 8:05 AM EDTStifel analyst Benjamin Burnett lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $33.00 (from $49.00) while maintaining a Buy rating.
The analyst commented, "Although yesterday's update has us scratching our heads and leaves us with a number of outstanding questions, we remain... More
Iovanace Biotherapeutics (IOVA) PT Lowered to $51 at Chardan Capital Markets on BLA Delay
May 19, 2021 7:58 AM EDTChardan Capital Markets analyst Geulah Livshits lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $51.00 (from $54.00) while maintaining a Buy rating.
The analyst commented, "Yesterday, after market close, Iovance Biotherapeutics announced revised guidance for BLA filing on tumor infiltrating lymphocyte (TIL)... More
Purple Innovation (PRPL) Prices 7.308M Shares Secondary Offering at $30/Sh
May 19, 2021 5:48 AM EDTPurple Innovation, Inc. (NASDAQ: PRPL), a leader in comfort innovation and the creator of the renowned Purple® Mattress, today announced the pricing of an underwritten secondary public offering of 7,308,792 shares of its Class A common stock to be sold by Coliseum Capital Partners, L.P., Coliseum Co-Invest Debt Fund, L.P., Blackwell Partners LLC Series A, and Coliseum Capital Co-Invest III, L.P. (collectively, the "Selling Stockholders"). The shares of Class A common stock are being sold at a price of... More
Roth Capital Upgrades QuickLogic (QUIK) to Buy
May 19, 2021 3:31 AM EDTRoth Capital analyst Seju Desilva upgraded QuickLogic (NASDAQ: QUIK) from Neutral to Buy with a price target of $8.00 (from $7.00).
The analyst comments "We believe QUIK rpresents a differentiated investment opportunity in sensor processing and licensing capability. QUIK reported softer than expected results impacted by... More

